27435854|t|Growth arrest of lung carcinoma cells (A549) by polyacrylate - anchored peroxovanadate by activating Rac1 - NADPH oxidase signalling axis
27435854|a|Hydrogen peroxide is often required in sublethal, millimolar concentrations to show its oxidant effects on cells in culture as it is easily destroyed by cellular catalase. Previously, we had shown that diperoxovanadate, a physiologically stable peroxovanadium compound, can substitute H2O2 effectively in peroxidation reactions. We report here that peroxovanadate when anchored to polyacrylic acid (PAPV) becomes a highly potent inhibitor of growth of lung carcinoma cells (A549). The early events associated with PAPV treatment included cytoskeletal modifications, increase in GTPase activity of Rac1, accumulation of the reactive oxygen species, and also increase in phosphorylation of H2AX (γH2AX), a marker of DNA damage. These effects persisted even at 24 h after removal of the compound and culminated in increased levels of p53 and p21 together with growth arrest. The PAPV -mediated growth arrest was significantly abrogated in cells pre-treated with the N-acetylcysteine, Rac1 knocked down by siRNA and DPI an inhibitor of NADPH oxidase. In conclusion, our results show that polyacrylate derivative of peroxovanadate efficiently arrests growth of A549 cancerous cells by activating the axis of Rac1 - NADPH oxidase leading to oxidative stress and DNA damage.
27435854	0	13	Growth arrest	T046	C0333951
27435854	17	31	lung carcinoma	T191	C0684249
27435854	32	37	cells	T025	C0007634
27435854	38	44	(A549)	T025	C4277577
27435854	48	60	polyacrylate	T109,T121,T122	C0597265
27435854	63	71	anchored	T061	C1293132
27435854	72	86	peroxovanadate	T121,T197	C0136151
27435854	90	100	activating	T052	C1879547
27435854	101	105	Rac1	T116,T126	C1430928
27435854	108	121	NADPH oxidase	T116,T126	C0068355
27435854	122	132	signalling	T044	C0086982
27435854	133	137	axis	T082	C1522496
27435854	138	155	Hydrogen peroxide	T121,T130,T197	C0020281
27435854	165	173	required	T169	C1514873
27435854	177	186	sublethal	T033	C0243095
27435854	188	213	millimolar concentrations	T081	C0392762
27435854	226	241	oxidant effects	T120	C0085403
27435854	245	261	cells in culture	T059	C1331092
27435854	278	287	destroyed	T052	C1948029
27435854	291	299	cellular	T025	C0007634
27435854	300	308	catalase	T116,T126	C0007367
27435854	340	356	diperoxovanadate	T121,T197	C0136151
27435854	360	375	physiologically	T169	C0205463
27435854	376	382	stable	T080	C0205360
27435854	383	406	peroxovanadium compound	T121,T197	C0136151
27435854	412	422	substitute	T169	C0559956
27435854	423	427	H2O2	T121,T130,T197	C0020281
27435854	428	439	effectively	T080	C1704419
27435854	443	465	peroxidation reactions	T067	C0178796
27435854	470	476	report	T170	C0684224
27435854	487	501	peroxovanadate	T121,T197	C0136151
27435854	507	515	anchored	T061	C1293132
27435854	519	535	polyacrylic acid	T109,T122	C1621338
27435854	536	542	(PAPV)	T121	C1254351
27435854	553	559	highly	T080	C0205250
27435854	560	566	potent	T080	C3245505
27435854	567	576	inhibitor	T080	C1999216
27435854	580	586	growth	T040	C0018270
27435854	590	604	lung carcinoma	T191	C0684249
27435854	605	610	cells	T025	C0007634
27435854	612	616	A549	T025	C4277577
27435854	623	628	early	T079	C1279919
27435854	629	635	events	T051	C0441471
27435854	636	651	associated with	T080	C0332281
27435854	652	656	PAPV	T121	C1254351
27435854	657	666	treatment	T169	C1522326
27435854	667	675	included	T052	C2700399
27435854	676	688	cytoskeletal	T026	C0010853
27435854	689	702	modifications	T033	C3840684
27435854	704	712	increase	T169	C0442805
27435854	716	731	GTPase activity	T044	C1149036
27435854	735	739	Rac1	T116,T126	C1430928
27435854	741	753	accumulation	T033	C4055506
27435854	761	784	reactive oxygen species	T123,T196	C0162772
27435854	795	803	increase	T169	C0442805
27435854	807	822	phosphorylation	T044	C0031715
27435854	826	830	H2AX	T116,T123	C1172465
27435854	831	838	(γH2AX)	T116,T123	C1567920
27435854	842	848	marker	T086	C0012872
27435854	852	862	DNA damage	T049	C0012860
27435854	870	877	effects	T080	C1280500
27435854	878	887	persisted	T078	C0549178
27435854	907	914	removal	T052	C1883720
27435854	922	930	compound	T080	C0205198
27435854	949	958	increased	T081	C0205217
27435854	959	965	levels	T080	C0441889
27435854	969	972	p53	T116,T123	C0080055
27435854	977	980	p21	T116,T123	C0288472
27435854	995	1008	growth arrest	T046	C0333951
27435854	1014	1018	PAPV	T121	C1254351
27435854	1029	1042	growth arrest	T046	C0333951
27435854	1047	1060	significantly	T078	C0750502
27435854	1061	1070	abrogated	T078	C1549072
27435854	1074	1079	cells	T025	C0007634
27435854	1080	1091	pre-treated	T079	C2709094
27435854	1101	1117	N-acetylcysteine	T116,T121	C0001047
27435854	1119	1123	Rac1	T116,T126	C1430928
27435854	1124	1136	knocked down	T063	C2350567
27435854	1140	1145	siRNA	T114,T123	C1099354
27435854	1150	1153	DPI	T109,T121	C0058381
27435854	1157	1166	inhibitor	T080	C1999216
27435854	1170	1183	NADPH oxidase	T116,T126	C0068355
27435854	1204	1211	results	T169	C1274040
27435854	1222	1234	polyacrylate	T109,T121,T122	C0597265
27435854	1249	1263	peroxovanadate	T121,T197	C0136151
27435854	1264	1275	efficiently	T080	C0442799
27435854	1276	1290	arrests growth	T046	C0333951
27435854	1294	1298	A549	T025	C4277577
27435854	1299	1314	cancerous cells	T025	C0007634
27435854	1318	1328	activating	T052	C1879547
27435854	1333	1337	axis	T082	C1522496
27435854	1341	1345	Rac1	T116,T126	C1430928
27435854	1348	1361	NADPH oxidase	T116,T126	C0068355
27435854	1373	1389	oxidative stress	T049	C0242606
27435854	1394	1404	DNA damage	T049	C0012860